Therapeutic effects of a cardiac hormone, named BNP, in patients with poorly controlled high levels of blood pressure

Update Il y a 4 ans
Reference: EUCTR2015-000577-13

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate safety and to determine most effective dose of subcutaneous nesiritide in patients with UHT.


Inclusion criteria

  • Uncontrolled hypertension (UHT, i.e. blood pressure ≥ 150/90, or ≥ 150/85 mm Hg in diabetic patients) despite treatment with at least two
  • different classes of antihypertensive medications

Links